BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 338983)

  • 1. Clinical trial with rifampicin in the treatment of leprosy (final report).
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1977 Jul; 49(3):339-43. PubMed ID: 338983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Pulsed' rifampicin therapy in leprosy. A clinical study.
    Girdhar BK; Desikan KV
    Lepr India; 1979 Oct; 51(4):475-80. PubMed ID: 392192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
    Girdhar BK; Ramu G; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):363-70. PubMed ID: 359925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial with rifampicin in the treatment of leprosy.
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1976 Oct; 48(4 Suppl):775-80. PubMed ID: 800236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
    Katoch K; Natarajan M; Bhatia AS; Yadav VS
    Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
    Dousset-Faure I; Millan J; Decazes JM; Languillon J
    Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
    Pattyn SR; André PS; Ferracci C; Baquillon G
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.